Adhd and Device occlusion
Summary:
Device occlusion is found among people with Adhd, especially for people who are male, 20-29 old.
The study analyzes which people have Device occlusion with Adhd. It is created by eHealthMe based on reports of 9 people who have Adhd from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Adhd?
Adhd (adhd-mental disorders that develop in children) is found to be associated with 598 drugs and 1,372 conditions by eHealthMe. Check the latest studies of Adhd.
What is Device occlusion?
Device occlusion is found to be associated with 617 drugs and 508 conditions by eHealthMe. Check the latest studies of Device occlusion.
9 people who have Adhd and Device Occlusion are studied.

Gender of people who have Adhd and experienced Device Occlusion *:
- female: 11.11 %
- male: 88.89 %
Age of people who have Adhd and experienced Device Occlusion *:
- 0-1: 0.0 %
- 2-9: 12.5 %
- 10-19: 0.0 %
- 20-29: 37.5 %
- 30-39: 25.0 %
- 40-49: 0.0 %
- 50-59: 25.0 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Stress And Anxiety: 3 people, 33.33%
- Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 33.33%
- Weakness: 2 people, 22.22%
- Oppositional Defiant Disorder (a childhood disorder described by the diagnostic and statistical manual of mental disorders): 2 people, 22.22%
- Affective Disorder (mental disorder): 2 people, 22.22%
- Blood Pressure Abnormal: 2 people, 22.22%
- Blood Testosterone Decreased: 2 people, 22.22%
- Diabetes: 2 people, 22.22%
- Erection Problems: 2 people, 22.22%
- Foetal Alcohol Syndrome (a pattern of mental and physical defects that can develop in a foetus in association with high levels of alcohol consumption in pregnancy): 2 people, 22.22%
Common drugs taken by these people *:
- Risperdal Consta: 4 people, 44.44%
- Lipitor: 3 people, 33.33%
- Zyprexa: 2 people, 22.22%
- Androgel: 2 people, 22.22%
- Artane: 2 people, 22.22%
- Ativan: 2 people, 22.22%
- Axiron: 2 people, 22.22%
- Depakote: 2 people, 22.22%
- Glucophage: 2 people, 22.22%
- Xylocaine: 2 people, 22.22%
Common symptoms for these people *:
- Peripheral Vascular Disorder: 2 people, 22.22%
- Angiopathy (generic term for a disease of the blood vessels): 2 people, 22.22%
- Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 2 people, 22.22%
- Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 2 people, 22.22%
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 11.11%
- Haematochezia (passage of stools containing blood): 1 person, 11.11%
- Gastroenteritis Escherichia Coli (inflammation of stomach and intestine caused by escherichia coli infection): 1 person, 11.11%
- Gait Disturbance: 1 person, 11.11%
- Fever: 1 person, 11.11%
- Fatigue (feeling of tiredness): 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Device occlusion?
Check whether Device occlusion is associated with a drug or a conditionRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Coskun, M., & Adak, I. , "Excessive and frequent menstrual bleeding with methylphenidate in an adolescent girl with attention-deficit hyperactivity disorder", Journal of clinical psychopharmacology, 2014 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Adhd (120,237 reports)
- Device occlusion (13,307 reports)
All the drugs that are associated with Device occlusion:
- Device occlusion (617 drugs)
All the conditions that are associated with Device occlusion:
- Device occlusion (508 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Device occlusion and Adhd, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Entresto and Vision Blurred for Women aged 40-49 - a second ago
- Drug interactions of Pantoprazole Sodium and Rasagiline Mesylate - 2 seconds ago
- Could Se cause Hypoglycemia? - 4 seconds ago
- Anger and drugs of ingredients of calcium - 4 seconds ago
- Drug interactions of Glucagen and Methotrexate - 4 seconds ago
- Prozac and Crying for Men aged 20-29 - 7 seconds ago
- Prednisone and Voriconazole drug interactions for women aged 60+ - 10 seconds ago
- Post-Traumatic Stress Disorder in Prilosec, how severe and when it was recovered? - 14 seconds ago
- Post Traumatic Stress Disorder in Prilosec, how severe and when it was recovered? - 14 seconds ago
- Drug Eruption and drugs of ingredients of mefenamic acid - 15 seconds ago